等待开盘 08-23 09:30:00 美东时间
+0.150
+0.96%
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
08-11 20:45
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency. Prasad, who had o...
08-11 18:25
Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.
07-30 23:07
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from $38 to $35.
07-30 06:18
uniQure shares are trading lower after the company reported worse-than-expected...
07-29 23:19
uniQure ( ($QURE) ) has provided an announcement. On July 29, 2025, uniQure N.V...
07-29 20:44
uniQure (NASDAQ:QURE) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.87) by 21.05 percent. This is a 40.52 percent increase over losses of $(1.16) per share from the same
07-29 19:05
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
uniQure (NASDAQ:QURE) is set to give its latest quarterly earnings report on Tu...
07-29 04:01